Mereo BioPharma Group PLC ADR (MREO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $48.71M
Last updated: Nov 17, 2026 at 4:36 PM ET
Mereo BioPharma Group PLC ADR (MREO) Statistics
Mereo BioPharma Group PLC ADR (MREO) has a market cap of $48.71M. It has 160.91M shares outstanding.
Total Valuation
| Market Cap | $48.71M |
|---|---|
| Latest price (Nov 17, 2026) | $0.27 |
Key Dates
The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 55.2x and 1.9x. Its year-end P/S ranged from 0.3x to 486.5x from 2021 to 2025.
| P/S Ratio | 55.2x |
|---|---|
| P/B Ratio | 1.9x |
Price Statistics
The stock is down 84.58% over 52 weeks and trades 12.90% below its 50-day average.
| Beta (1Y) | 1.70 |
|---|---|
| 52-Week Change | -84.58% |
| 1-Month Change | -9.14% |
| 3-Month Change | -11.88% |
| 6-Month Change | +15.34% |
| 5-Year Change | -87.13% |
| Total Return (1Y) | -84.58% |
| Total Return (3Y CAGR) | -49.08% |
| Total Return (5Y CAGR) | -33.19% |
| Max Drawdown (1Y) | -89.73% |
| Max Drawdown (3Y) | -95.13% |
| Sharpe Ratio (1Y) | -0.83 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $0.31 |
| 200-Day Average | $0.32 |
| 52-Week Range | $0.20 to $2.37 |
| RSI (14 Days) | 39.5 |
| Average Volume (20 Days) | 682.79K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.22x current liabilities, and total debt is 0.02x shareholder equity.
| Current Ratio | 5.22x |
|---|---|
| Quick Ratio | 5.22x |
| Debt / Equity | 0.02x |
| Interest Coverage | -419.15x |
Returns and Efficiency
Return on invested capital is -116.15% over the last 12 months, against a 5-year average of -45.60%.
| Return on Assets (ROA) | -91.02% |
|---|---|
| Return on Invested Capital (ROIC) | -116.15% |
| ROIC (5Y Average) | -45.60% |
| Receivables Turnover | 0.63x |
Scores
MREO has an Altman Z-Score of -22.37, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -22.37 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MREO
What is MREO's market cap?
Mereo BioPharma Group PLC ADR has a market cap of $48.71M.
How many shares of MREO are outstanding?
Mereo BioPharma Group PLC ADR has 160.91M shares outstanding. The count is up 0.57% from a year earlier.
Does MREO pay a dividend?
No. Mereo BioPharma Group PLC ADR does not pay a dividend.
MREO pages: Overview, Charting, Statistics, Valuation, Competitors